Using cytokine-induced killer cells, sufficient in vitro killing of CD133+ pancreatic (SW1990) and hepatic cancer (Hep3B) cancer cells was mediated with additional administration of the bispecific antibody. The gene discussed is PROM1; the disease is cancer.